Fig. 1From: Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validationThe design profile of the current study. Hepatic IR: hepatic insulin resistance; BP: biological process; CC: cellular component; MF: molecular function. The green box indicates Schematic structure of EGFR. On the left side of Fisetin is its chemical structureBack to article page